Iran Leads in Advanced Medical Treatments with Radiopharmaceuticals and Plasma Therapy

According to Khabaronline, an Iranian news agency, Eslami stated that the Atomic Energy Organization is now a leading force in the development and application of radiopharmaceuticals and plasma-based therapies.

He emphasized that domestic expertise in innovative medical technologies, particularly plasma medicine, is effective and sustainable. The newly opened clinic, with a national mandate, offers both outpatient and inpatient services.

The clinic primarily focuses on treating chronic wounds, including diabetic ulcers, pressure sores, and post-surgical wounds in cancer patients, which are often slow to heal and prone to infection. Over the past two years, more than 2,500 patients have been treated and recovered at plasma therapy centers across Iran.

Eslami also highlighted the significance of the Second Plasma Medicine Congress and the first joint congress on innovative cancer therapies, noting that such scientific collaboration demonstrates Iran’s capacity in cutting-edge medical technologies and plays a crucial role in combating cancer, which remains an aggressive health challenge in the country.

He concluded by stating that combining radiopharmaceuticals with new medical technologies opens a new chapter in Iran’s healthcare sector. By raising awareness among both medical professionals and the general public, these innovations can deliver more sustainable and effective outcomes, particularly for cancer patients.